Recent Quarter Total Invested
$3.86 M
Recent Quarter Institutional Ownership Percentage
3.89%
Total Invested of Last Quarter
$5.93 M
Ownership Percentage of Last Quarter
3.93%
Armata Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 634,033 | $1.74 M | -0.41% | 1.76% |
| VANGUARD GROUP INC | 08/13/2024 | 205,753 | $565,821 | 29.23% | 0.57% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 106,489 | $292,923 | 6.61% | 0.29% |
| EDGEWOOD MANAGEMENT LLC | 08/13/2024 | 100,000 | $275,000 | 0.00% | 0.28% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 90,382 | $248,551 | -18.12% | 0.25% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 64,012 | $176,033 | -27.10% | 0.18% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 49,700 | $136,675 | 100.00% | 0.14% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 48,196 | $132,539 | -6.23% | 0.13% |
| STATE STREET CORP | 08/14/2024 | 40,300 | $110,825 | 0.00% | 0.11% |
| SEACREST WEALTH MANAGEMENT, LLC | 07/22/2024 | 34,954 | $96,124 | 6.64% | 0.10% |
| BLACKROCK INC. | 08/13/2024 | 22,921 | $63,033 | -3.97% | 0.06% |
| NORTHERN TRUST CORP | 08/14/2024 | 19,273 | $53,001 | -0.10% | 0.05% |
| CITADEL ADVISORS LLC | 08/14/2024 | 16,481 | $45,323 | -8.26% | 0.05% |
| CAPTRUST FINANCIAL ADVISORS | 08/15/2024 | 13,140 | $36,135 | 0.00% | 0.04% |
| CITADEL ADVISORS LLC | 08/14/2024 | 7,000 | $19,250 | 100.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 5,064 | $13,926 | 198.41% | 0.01% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 1,908 | $5,248 | -91.49% | 0.01% |
| TRIFECTA CAPITAL ADVISORS, LLC | 08/07/2024 | 714 | $1,964 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 08/16/2024 | 571 | $1,570 | 0.00% | 0.00% |
| SALEM INVESTMENT COUNSELORS INC | 07/11/2024 | 100 | $275 | 0.00% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2024 | 100 | $275 | -50.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2024 | 27 | $74 | 3.85% | 0.00% |
| MORGAN STANLEY | 10/17/2024 | 2 | $6 | -99.53% | 0.00% |
| UBS GROUP AG | 08/14/2024 | 1 | $3 | -99.87% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 1 | $1 | -98.84% | 0.00% |
| HOUSEHOLDER GROUP ESTATE & RETIREMENT SPECIALIST, LLC | 07/17/2024 | 0 | $0 | -100.00% | 0.00% |
Armata Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ARMP shares?
During the previous two years, 20 institutional investors and hedge funds held shares of Armata Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BANK OF AMERICA CORP /DE/: 634,033
VANGUARD GROUP INC: 205,753
GEODE CAPITAL MANAGEMENT, LLC: 106,489
EDGEWOOD MANAGEMENT LLC: 100,000
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 90,382
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 64,012
-
What percentage of Armata Pharmaceuticals, Inc. stock is owned by institutional investors?
3.89% of Armata Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ARMP ?
Institutional investors have bought a total of 1.37 M shares in the last 24 months. This purchase volume represents approximately $3.12 M in transactions.